Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2018-08-15, Stock:ABBV, The news for the past five days is as follows:
2018-08-08: NEWS1: Mylan Exploring Options As 'Unsustainable' Trends Hound Sales, Profit.NEWS2: Mylan (MYL) Q2 Earnings and Revenues Miss, Guidance Cut.NEWS3: Mylan (MYL) Q2 Earnings and Revenues Miss, Guidance Cut.NEWS4: Mylan (MYL) Q2 Earnings and Revenues Miss, Guidance Cut.NEWS5: These Products Contributed to Pfizer’s Growth in Q2 2018.NEWS6: Understanding AbbVie’s Q2 2018 Operational Performance.NEWS7: What Does AbbVie’s Valuation Trend Indicate?.NEWS8: AbbVie’s Financial Performance in Q2 2018.NEWS9: Analyst Expectations for AbbVie and Its Peers in August.NEWS10: Examining Pfizer’s Performance by Geography in Q2 2018.NEWS11: What Does Bristol-Myers Squibb’s Valuation Trend Indicate?.
2018-08-09: NEWS1: Cramer Remix: Trade sanctions are hurting hedge funds the most.NEWS2: Cramer's lightning round: Coal may be in a renaissance, but don't buy the stocks.NEWS3: NYSE trader: Expect stocks to churn this August.NEWS4: CLASS ACTION UPDATE for FPI and ABBV: Levi & Korsinsky, LLP Reminds Investors of Class Actions on Behalf of Shareholders.NEWS5: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV.
2018-08-10: NEWS1: You Better Be Careful with Merck Stock, Especially at These Highs.NEWS2: Jim Cramer Weighs In On Arch Coal, AbbVie And More.
2018-08-13: NEWS1: SHAREHOLDER ALERT: HAIR RMTI ABBV GDS NLSN ZN SBGI ORCL: The Law Offices of Vincent Wong Reminds Investors of Important Class Action Deadlines.NEWS2: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AbbVie Inc. - ABBV.NEWS3: Noteworthy ETF Inflows: MTUM, BA, JPM, ABBV.NEWS4: Noteworthy ETF Inflows: MTUM, BA, JPM, ABBV.NEWS5: Top Analyst Reports: Mastercard, AbbVie, Twenty-First Century Fox & More.NEWS6: Why Enanta Stock Is Still a Strong Buy With Huge Upside.NEWS7: Why Enanta Stock Is Still a Strong Buy With Huge Upside.NEWS8: Why Enanta Stock Is Still a Strong Buy With Huge Upside.
2018-08-14: NEWS1: See what the IHS Markit Score report has to say about AbbVie Inc..NEWS2: Better Buy: AbbVie Inc. vs. Johnson & Johnson.NEWS3: Better Buy: AbbVie Inc. vs. Johnson & Johnson.NEWS4: Better Buy: AbbVie Inc. vs. Johnson & Johnson.

Answer: Rise